Finally, the competitive landscape of the sulphamic acid market is also worth noting. With numerous manufacturers operating globally, competition can drive prices down, particularly in regions with a surplus of production capacity. Conversely, in markets where production is concentrated among a few key players, prices may remain elevated due to reduced competitive pressure.
The runaway outbreak has sparked global concern. As the world’s largest API exporters, the supply pattern of China and India has been affected. At the same time, with the emergence of a new round of global trade protectionism and increased demand for the security of the pharmaceutical industry chain due to the epidemic, China’s API industry faces new challenges and must accelerate the transformation and upgrading from a big country to a strong one. To this end, “Pharmaceutical Economic News” specially launched the special planning of “API road to Strong Country”.